Altimmune, Inc. (ALT) Tops Q4 EPS by 7c
Tweet
Share
E-mailGet Alerts ALT Hot Sheet
Join SI Premium – FREE
Altimmune, Inc. (NASDAQ: ALT) reported Q4 EPS of ($0.43), $0.07 better than the analyst estimate of ($0.50).
For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citigroup (C) Tops Q2 EPS by 42c
- Citi opens 90-day upside catalyst watch on Full Truck Alliance
- Fastenal (FAST) Reports In-Line Q2 EPS, Beats on Revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
